On March 12, Roche announced that it has obtained a license to manufacture a new weight loss drug from Danish biotech company Zealand Pharma at a price of up to US$5.3 billion.

Zhitongcaijing · 03/12 08:17
On March 12, Roche announced that it has obtained a license to manufacture a new weight loss drug from Danish biotech company Zealand Pharma at a price of up to US$5.3 billion.